Long non-coding RNAs and hepatocellular carcinoma (Review)
- Authors:
- Fu-Jun Yu
- Jian-Jian Zheng
- Pei-Hong Dong
- Xiao-Ming Fan
-
Affiliations: Department of Gastroenterology, Jinshan Hospital of Fudan University, Jinshan, Shanghai 201508, P.R. China, Wenzhou Key Laboratory of Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China, Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China - Published online on: September 25, 2014 https://doi.org/10.3892/mco.2014.429
- Pages: 13-17
This article is mentioned in:
Abstract
|
Zheng J, Lin Z, Dong P, et al: Activation of hepatic stellate cells is suppressed by microRNA-150. Int J Mol Med. 32:17–24. 2013.PubMed/NCBI | |
|
Zheng J, Dong P, Gao S, Wang N and Yu F: High expression of serum miR-17-5p associated with poor prognosis in patients with hepatocellular carcinoma. Hepatogastroenterology. 60:549–552. 2013.PubMed/NCBI | |
|
Zheng J, Wu C, Lin Z, et al: Curcumin up-regulates phosphatase and tensin homologue deleted on chromosome 10 through microRNA-mediated control of DNA methylation - a novel mechanism suppressing liver fibrosis. FEBS J. 281:88–103. 2014. View Article : Google Scholar | |
|
Huang B and Zhang R: Regulatory non-coding RNAs: revolutionizing the RNA world. Mol Biol Rep. Feb 19–2014.(Epub ahead of print). | |
|
Gehrau RC, Mas VR, Villamil FG, et al: MicroRNA signature at the time of clinical HCV recurrence associates with aggressive fibrosis progression post-liver transplantation. Am J Transplant. 13:729–737. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Dong P, Yu F, Fan X, Lin Z, Chen Y and Li J: Inhibition of ATIR by shRNA prevents collagen synthesis in hepatic stellate cells. Mol Cell Biochem. 344:195–202. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Gomes AQ, Nolasco S and Soares H: Non-coding RNAs: multi-tasking molecules in the cell. Int J Mol Sci. 14(8): 16010–16039. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Gao SM, Xing CY, Chen CQ, Lin SS, Dong PH and Yu FJ: miR-15a and miR-16-1 inhibit the proliferation of leukemic cells by down-regulating WT1 protein level. J Exp Clin Cancer Res. 30(110)2011.PubMed/NCBI | |
|
Yu FJ, Dong PH, Fan XF, Lin Z, Chen YP and Li J: Downregulation of angiotensin II by shRNA reduces collagen synthesis in hepatic stellate cells. Int J Mol Med. 25:801–806. 2010.PubMed/NCBI | |
|
Chen SL, Zheng MH, Yang T, Song M and Chen YP: Disparate profiles of dys-regulated miRNAs in activated hepatic stellate cells. Hepatology. 57:1285–1286. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Kitagawa M, Kotake Y and Ohhata T: Long noncoding RNAs involved in cancer development and cell fate determination. Curr Drug Targets. 13:1616–1621. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Yoon JH, Abdelmohsen K, Srikantan S, et al: LincRNA-p21 suppresses target mRNA translation. Mol Cell. 47:648–655. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Yoon JH, Abdelmohsen K and Gorospe M: Posttranscriptional gene regulation by long noncoding RNA. J Mol Biol. 425:3723–3730. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Q, Chen CY, Yedavalli VS and Jeang KT: NEAT1 long noncoding RNA and paraspeckle bodies modulate HIV-1 post-transcriptional expression. MBio. 4:e00596–e00512. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Qiu MT, Hu JW, Yin R and Xu L: Long noncoding RNA: an emerging paradigm of cancer research. Tumour Biol. 34:613–620. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Danko CG, Hah N, Luo X, et al: Signaling pathways differentially affect RNA polymerase II initiation, pausing, and elongation rate in cells. Mol Cell. 50:212–222. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Moran VA, Perera RJ and Khalil AM: Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res. 40:6391–6400. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Gibb EA, Vucic EA, Enfield KS, et al: Human cancer long non-coding RNA transcriptomes. PLoS One. 6:e259152011. View Article : Google Scholar : PubMed/NCBI | |
|
Bussemakers MJ, van Bokhoven A, Verhaegh GW, et al: DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res. 59:5975–5979. 1999.PubMed/NCBI | |
|
van Devondervoort II, Gordebeke PM, Khoshab N, et al: Long non-coding RNAs in neurodevelopmental disorders. Front Mol Neurosci. 6(53)2013.PubMed/NCBI | |
|
Gutschner T and Diederichs S: The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 9:703–719. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Weikard R, Hadlich F and Kuehn C: Identification of novel transcripts and noncoding RNAs in bovine skin by deep next generation sequencing. BMC Genomics. 14(789)2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Yang L and Chen LL: Life without A tail: new formats of long noncoding RNAs. Int J Biochem Cell Biol. Oct 26–2013.(Epub ahead of print). View Article : Google Scholar | |
|
Nadal-Ribelles M, Solé C, Xu Z, Steinmetz LM, de Nadal E and Posas F: Control of Cdc28 CDK1 by a stress-induced lncRNA. Mol Cell. 53:549–561. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Imamura K, Imamachi N, Akizuki G, et al: Long noncoding RNA NEAT1-dependent SFPQ relocation from promoter region to paraspeckle mediates IL8 expression upon immune stimuli. Mol Cell. 53:393–406. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Li CH and Chen Y: Targeting long non-coding RNAs in cancers: progress and prospects. Int J Biochem Cell Biol. 45:1895–1910. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Yang F, Yi F, Han X, Du Q and Liang Z: MALAT-1 interacts with hnRNP C in cell cycle regulation. J FEBS Lett. 587:3175–3181. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Shi X, Sun M, Liu H, Yao Y and Song Y: Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 339:159–166. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Lai MC, Yang Z, Zhou L, et al: Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol. 29:1810–1816. 2012. View Article : Google Scholar | |
|
Rinn JL, Kertesz M, Wang JK, et al: Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell. 129:1311–1323. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Sørensen KP, Thomassen M, Tan Q, et al: Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer. Breast Cancer Res Treat. 142:529–536. 2013.PubMed/NCBI | |
|
Zhang JX, Han L, Bao ZS, et al: HOTAIR, a cell cycle-associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma. Neuro Oncol. 15:1595–1603. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Chen FJ, Sun M, Li SQ, et al: Upregulation of the long non-coding RNA HOTAIR promotes esophageal squamous cell carcinoma metastasis and poor prognosis. Mol Carcinog. 52:908–915. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ishibashi M, Kogo R, Shibata K, et al: Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma. Oncol Rep. 29:946–950. 2013.PubMed/NCBI | |
|
Geng YJ, Xie SL, Li Q, Ma J and Wang GY: Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression. J Int Med Res. 39:2119–2128. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Yang Z, Zhou L, Wu LM, et al: Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol. 18:1243–1250. 2011. View Article : Google Scholar | |
|
Matouk I, Raveh E, Ohana P, et al: The increasing complexity of the oncofetal h19 gene locus: functional dissection and therapeutic intervention. Int J Mol Sci. 14:4298–4316. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ratajczak MZ: Igf2-H19, an imprinted tandem gene, is an important regulator of embryonic development, a guardian of proliferation of adult pluripotent stem cells, a regulator of longevity, and a ‘passkey’ to cancerogenesis. Folia Histochem Cytobiol. 50:171–179. 2012.PubMed/NCBI | |
|
Necsulea A, Soumillon M, Warnefors M, et al: The evolution of lncRNA repertoires and expression patterns in tetrapods. Nature. 505:635–640. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Monnier P, Martinet C, Pontis J, Stancheva I, Ait-Si-Ali S and Dandolo L: H19 lncRNA controls gene expression of the imprinted gene network by recruiting MBD1. Proc Natl Acad Sci USA. 110:20693–20698. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Yu LL, Chang K, Lu LS, et al: Lentivirus-mediated RNA interference targeting the H19 gene inhibits cell proliferation and apoptosis in human choriocarcinoma cell line JAR. BMC Cell Biol. 14(26)2013.PubMed/NCBI | |
|
Gao T, He B, Pan Y, et al: H19 DMR methylation correlates to the progression of esophageal squamous cell carcinoma through IGF2 imprinting pathway. Clin Transl Oncol. 16:410–417. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Luo M, Li Z, Wang W, Zeng Y, Liu Z and Qiu J: Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression. FEBS J. 280:1709–1716. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Matouk IJ, DeGroot N, Mezan S, et al: The H19 non-coding RNA is essential for human tumor growth. PLoS One. 2:e8452007. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang L, Yang F, Yuan JH, et al: Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis. 34:577–586. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Yoshimizu T, Miroglio A, Ripoche MA, et al: The H19 locus acts in vivo as a tumor suppressor. Proc Natl Acad Sci USA. 105:12417–12422. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Kameswaran V, Bramswig NC, McKenna LB, et al: Epigenetic regulation of the DLK1-MEG3 microRNA cluster in human type 2 diabetic islets. Cell Metab. 19:135–145. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Tran DA, Bai AY, Singh P, Wu X and Szabo PE: Characterization of the imprinting signature of mouse embryo fibroblasts by RNA deep sequencing. Nucleic Acids Res. 42:1772–1783. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Benetatos L, Voulgaris E and Vartholomatos G: DLK1-MEG3 imprinted domain microRNAs in cancer biology. Crit Rev Eukaryot Gene Expr. 22:1–15. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Qin R, Chen Z, Ding Y, Hao J, Hu J and Guo F: Long non-coding RNA MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis. Neoplasma. 60:486–492. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ying L, Huang Y, Chen H, et al: Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. Mol Biosyst. 9:407–411. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Balik V, Srovnal J, Sulla I, et al: MEG3: a novel long noncoding potentially tumour-suppressing RNA in meningiomas. J Neurooncol. 112:1–8. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou Y, Zhang X and Klibanski A: MEG3 noncoding RNA: a tumor suppressor. J Mol Endocrinol. 48:R45–R53. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Braconi C, Kogure T, Valeri N, et al: microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene. 30:4750–4756. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Anwar SL, Krech T, Hasemeier B, et al: Loss of imprinting and allelic switching at the DLK1-MEG3 locus in human hepatocellular carcinoma. PLoS One. 7:e494622012. View Article : Google Scholar : PubMed/NCBI | |
|
He Y, Meng XM, Huang C, et al: Long noncoding RNAs: novel insights into hepatocelluar carcinoma. Cancer Lett. 344:20–27. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Avellino AM, Grant GA, Harris AB, Wallace SK and Shaw CM: Recurrent intracranial Masson's vegetant intravascular hemangioendothelioma. Case report and review of the literature. J Neurosurg. 91:308–312. 1999. | |
|
Yuan SX, Yang F, Yang Y, et al: Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy. Hepatology. 56:2231–2241. 2012.PubMed/NCBI | |
|
Zhao Y, Guo Q, Chen J, Hu J, Wang S and Sun Y: Rol. of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation. Oncol Rep. 31:358–364. 2014.PubMed/NCBI | |
|
Panzitt K, Tschernatsch MM, Guelly C, et al: Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology. 132:330–342. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Xie H, Ma H and Zhou D: Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma. Biomed Res Int. 2013(136106)2013.PubMed/NCBI | |
|
Matouk IJ, Abbasi I, Hochberg A, Galun E, Dweik H and Akkawi M: Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis. Eur J Gastroenterol Hepatol. 21:688–692. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Wang J, Liu X, Wu H, et al: CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res. 38:5366–5383. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y, Pan S, Liu L, et al: A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population. PLoS One. 7:e351452012. View Article : Google Scholar : PubMed/NCBI | |
|
Du Y, Kong G, You X, et al: Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J Biol Chem. 287:26302–26311. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Huang JF, Guo YJ, Zhao CX, et al: Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin. Hepatology. 57:1882–1892. 2013. View Article : Google Scholar | |
|
Yang F, Zhang L, Huo XS, et al: Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology. 54:1679–1689. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Yang H, Zhong Y, Xie H, et al: Induction of the liver cancer-down-regulated long noncoding RNA uc002mbe.2 mediates trichostatin-induced apoptosis of liver cancer cells. Biochem Pharmacol. 85:1761–1769. 2013. View Article : Google Scholar : PubMed/NCBI |
